The next focusIR Investor Webinar takes places on 14th May with guest speakers from Blue Whale Growth Fund, Taseko Mines, Kavango Resources and CQS Natural Resources fund. Please register here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksSysgroup Regulatory News (SYS)

Share Price Information for Sysgroup (SYS)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 34.00
Bid: 32.00
Ask: 36.00
Change: 0.00 (0.00%)
Spread: 4.00 (12.50%)
Open: 0.00
High: 0.00
Low: 0.00
Prev. Close: 34.00
SYS Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Form 8 (OPD) System C Healthcare

3 Mar 2011 08:00

RNS Number : 2509C
McKesson Corporation
03 March 2011
 



FORM 8 (OPD)

 

PUBLIC OPENING POSITION DISCLOSURE BY A PARTY TO AN OFFER

Rules 8.1 and 8.2 of the Takeover Code (the "Code")

 

1. KEY INFORMATION

 

(a) Identity of the party to the offer making the disclosure:

McKesson Corporation

("McKesson")

(b) Owner or controller of interests and short positions disclosed, if different from 1(a):

The naming of nominee or vehicle companies is insufficient

Not applicable

(c) Name of offeror/offeree in relation to whose relevant securities this form relates:

Use a separate form for each party to the offer

System C Healthcare plc

("System C")

(d) Is the party to the offer making the disclosure the offeror or the offeree?

OFFEROR

(e) Date position held:

3 March 2011

(f) Has the party previously disclosed, or is it today disclosing, under the Code in respect of any other party to this offer?

NO

 

2. POSITIONS OF THE PARTY TO THE OFFER MAKING THE DISCLOSURE

 

(a) Interests and short positions in the relevant securities of the offeror or offeree to which the disclosure relates

 

Class of relevant security:

 

1p ordinary

 

 

Interests

Short positions

Number

%

Number

%

(1) Relevant securities owned and/or controlled:

Nil

Nil

Nil

Nil

(2) Derivatives (other than options):

Nil

Nil

Nil

Nil

(3) Options and agreements to purchase/sell:

Nil

Nil

Nil

Nil

 

TOTAL:

Nil

Nil

Nil

Nil

 

All interests and all short positions should be disclosed.

 

Details of any open derivative or option positions, or agreements to purchase or sell relevant securities, should be given on a Supplemental Form 8 (Open Positions).

 

Details of any securities borrowing and lending positions or financial collateral arrangements should be disclosed on a Supplemental Form 8 (SBL).

 

(b) Rights to subscribe for new securities

 

Class of relevant security in relation to which subscription right exists:

None

Details, including nature of the rights concerned and relevant percentages:

None

 

If there are positions or rights to subscribe to disclose in more than one class of relevant securities of the offeror or offeree named in 1(c), copy table 2(a) or (b) (as appropriate) for each additional class of relevant security.

 

(c) Irrevocable commitments and letters of intent

 

Details of any irrevocable commitments or letters of intent procured by the party to the offer making the disclosure or any person acting in concert with it (see Note 3 on Rule 2.11 of the Code):

McKesson has received irrevocable undertakings from each of the System C directors (as set out below) in respect of their entire holdings in System C shares, representing approximately 4.29 per cent. of the existing issued ordinary share capital of System C

 

McKesson has also received irrevocable undertakings from Liontrust Asset Management plc ("Liontrust"), Gartmore Investment Management Limited ("Gartmore") from Guy Hands (as set out below) in respect of holdings or shares over which they have discretionary voting control, representing approximately 19.83 per cent. of the existing issued ordinary share capital of System C.

 

Finally, McKesson has received a letter of intent from BlackRock Investment Management (UK) Limited ("Blackrock") in respect of 10,656,454 System C ordinary shares in which they have discretionary voting control as at close of business on 1 March 2011, representing 9.2 per cent. of the existing issued ordinary share capital of System C.

 

In aggregate, McKesson has, therefore, received irrevocable undertakings and letters of intent to vote in favour of the Scheme in respect of 38,737,854 System C Shares, representing 33.28 per cent. of the existing issued ordinary share capital of System C.

 

Name

No. of ordinary shares

%

Directors

Hedley Mayor

Nil

Nil

John Forrest

22,223

0.02

Thomas Chambers

22,223

0.02

Markus Bolton

4,174,324

3.59

Ian Denley

480,026

0.41

Jim Horsburgh

300,000

0.29

Total

4,998,796

4.29

Certain shareholders

Blackrock

10,656,454

9.16

Liontrust

14,672,512

12.61

Gartmore

5,779,102

4.97

Guy Hands

2,630,990

2.26

Total

33,739,058

28.99

Total directors and shareholders

38,737,854

33.28

 

 

 

3. POSITIONS OF PERSONS ACTING IN CONCERT WITH THE PARTY TO THE OFFER MAKING THE DISCLOSURE

 

Details of any interests, short positions and rights to subscribe of any person acting in concert with the party to the offer making the disclosure:

 

HSBC Bank plc

 

It was not practicable in the time available to have completed these enquiries. A further Opening Position Disclosure containing all relevant details will be made as soon as possible, and in any event before 12 noon the day falling 10 business days after this announcement.

 

 

 

If there are positions or rights to subscribe to disclose in more than one class of relevant securities of the offeror or offeree named in 1(c), copy table 3 for each additional class of relevant security.

 

Details of any open derivative or option positions, or agreements to purchase or sell relevant securities, should be given on a Supplemental Form 8 (Open Positions).

 

Details of any securities borrowing and lending positions or financial collateral arrangements should be disclosed on a Supplemental Form 8 (SBL).

 

4. OTHER INFORMATION

 

(a) Indemnity and other dealing arrangements

 

Details of any indemnity or option arrangement, or any agreement or understanding, formal or informal, relating to relevant securities which may be an inducement to deal or refrain from dealing entered into by the party to the offer making the disclosure or any person acting in concert with it:

If there are no such agreements, arrangements or understandings, state "none"

 

None

 

 

(b) Agreements, arrangements or understandings relating to options or derivatives

 

Details of any agreement, arrangement or understanding, formal or informal, between the party to the offer making the disclosure, or any person acting in concert with it, and any other person relating to:

(i) the voting rights of any relevant securities under any option; or

(ii) the voting rights or future acquisition or disposal of any relevant securities to which any derivative is referenced:

If there are no such agreements, arrangements or understandings, state "none"

 

None

 

 

(c) Attachments

 

Are any Supplemental Forms attached?

 

Supplemental Form 8 (Open Positions)

NO

Supplemental Form 8 (SBL)

NO

 

 

Date of disclosure:

3 March 2011

Contact name:

Laureen Seegar

Telephone number:

+1 (415) 983 8300

 

Public disclosures under Rule 8 of the Code must be made to a Regulatory Information Service and must also be emailed to the Takeover Panel at monitoring@disclosure.org.uk. The Panel's Market Surveillance Unit is available for consultation in relation to the Code's dealing disclosure requirements on +44 (0)20 7638 0129.

 

The Code can be viewed on the Panel's website at www.thetakeoverpanel.org.uk.

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
FEEDKNDDPBKKBNK
Date   Source Headline
30th Apr 20247:00 amRNSTrading Update
29th Feb 20248:49 amRNSHolding(s) in Company
29th Feb 20247:00 amRNSHolding(s) in Company
6th Feb 20247:00 amRNSBoard Change, Update & Change of Registered Office
12th Dec 20234:16 pmRNSBoard Changes
27th Nov 20237:00 amRNSHalf-year Report
1st Nov 20237:00 amRNSTrading Update & Notice of Results
26th Sep 20237:00 amRNSBoard Changes and Change of Adviser
22nd Sep 20232:22 pmRNSResult of AGM
5th Sep 20237:00 amRNSExercise of options and PDMR dealings
17th Aug 20237:00 amRNSNotice of AGM and Availability of ARA
7th Aug 20237:00 amRNSDirector / PDMR dealing
26th Jun 20237:01 amRNSBoard Changes and related party transactions
26th Jun 20237:00 amRNSFinal results for the year ended 31 March 2023
26th May 202312:05 pmRNSExercise of options and director dealing
26th May 20237:00 amRNSBoard Changes
26th Apr 202311:04 amRNSHolding(s) in Company
19th Apr 202310:08 amRNSHolding(s) in Company
18th Apr 20236:00 pmRNSHolding(s) in Company
18th Apr 20237:00 amRNSExec LTIP Awards
18th Apr 20237:00 amRNSHolding(s) in Company
17th Apr 20235:41 pmRNSHolding(s) in Company
17th Apr 20235:37 pmRNSHolding(s) in Company
17th Apr 20237:00 amRNSTrading Update and Notice of Results
1st Feb 20237:00 amRNSChange of Adviser
31st Jan 20235:49 pmRNSSchedule 2(g) Update
21st Nov 20227:00 amRNSHalf-year Report
3rd Nov 20227:00 amRNSInvestor Presentation
28th Oct 20224:40 pmRNSSecond Price Monitoring Extn
28th Oct 20224:35 pmRNSPrice Monitoring Extension
26th Oct 20227:00 amRNSTrading Update
10th Oct 20225:28 pmRNSHolding(s) in Company
8th Sep 20221:12 pmRNSResult of AGM
28th Jul 202211:09 amRNSNotice of AGM & Availability of Annual Report
22nd Jun 20227:00 amRNSExecutive LTIP Awards
20th Jun 20227:00 amRNSFinal Results
8th Jun 202212:22 pmRNSInvestor Presentation
27th Apr 20227:00 amRNSAcquisition of Independent Network Solutions Ltd
19th Apr 20227:00 amRNSTrading Update and Notice of Results
5th Apr 20227:00 amRNSAcquisition of Truststream Security Solutions Ltd
4th Apr 20227:00 amRNSChange of Adviser
1st Apr 20225:05 pmRNSSchedule 2(g) update
22nd Nov 20217:00 amRNSHalf-year Report
8th Nov 202111:59 amRNSHolding(s) in Company
2nd Nov 20217:00 amRNSInvestor Presentation
29th Oct 20219:05 amRNSSecond Price Monitoring Extn
29th Oct 20219:00 amRNSPrice Monitoring Extension
29th Oct 20217:00 amRNSTrading Update and Notice of Results
16th Sep 202111:21 amRNSResult of AGM
23rd Aug 20217:00 amRNSNotice of AGM and Annual Report 2021

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.